DNA Vaccines Market Growth 2019-2024
Verfasser: riyasharma24mr on Monday, 10 June 2019The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.
North America is the largest consumption place, with a revenue market share nearly 58% in 2017. Following North America, Europe is the second largest consumption place with the revenue market share of 28% in 2017. Asia-Pacific is also an important sales area, especially in China.
Report Sample includes:
- Table of Contents
- List of Tables & Figures
- Charts
- Research Methodology
Get FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-dna-vaccines-2019-2...
According to this study, over the next five years the DNA Vaccines market will register a 8.3% CAGR in terms of revenue, the global market size will reach US$ 5490 million by 2024, from US$ 3690 million in 2019.
In particular, this report presents the global market share (sales and revenue) of key companies in DNA Vaccines business, shared in Chapter 3.